Cancer remains one of the most pressing health challenges globally. In recent years, a new wave of oncology drug development has emerged, driven by advances in immunotherapies, targeted delivery systems, and precision medicine. This event brings together leaders from emerging biotech companies, established pharmaceutical firms, and academic innovators to explore how the next generation of cancer therapeutics is being developed, translated, and commercialised.
The event will focus primarily on the biotech sector – especially late preclinical to early clinical-stage companies – with invited participation from academic, clinical, and investor groups to foster knowledge sharing and cross-sector connections.
It aims to spotlight Melbourne-based innovation while addressing shared translational challenges and building a culture of openness around both successes and setbacks in oncology drug development. Register now to secure your place, tickets for this event are limited.
info@wilam.comAn initiative ofBioMelbourne NetworkLevel 6, HWT Tower40 City RoadSouthbank, VIC 3006
Wilam means home in the Woi-wurrung language of the Wurundjeri People of the Kulin Nation, the Traditional Owners of the lands on which we are based.We respectfully acknowledge the Traditional Custodians of the unceded lands and waters of Victoria, the Bunurong, Eastern Maar, Gunaikurnai, Wadawurrung and Wurundjeri Woi-wurrung peoples, on which we live and work. We pay respect to their Elders past and present. We acknowledge the significant contribution that they and other Aboriginal and Torres Strait Islander people have made and continue to make to the research and knowledge systems that inform our community and our sector. We acknowledge that Aboriginal and Torres Strait Islander people continue to live in a spiritual and sacred relationship with this country and recognise our responsibility to continue to work towards reconciliation.